A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States
Top Cited Papers
- 1 January 2021
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (1) , 25-32
Abstract
Before policymakers authorize a new health care program, they compare the program's expected cost against its expected benefit. In formal analyses, benefit is often measured in quality-adjusted lif... Visual U.S. Health Opportunity Cost Threshold for Cost-Effectiveness Analysis Before policymakers authorize a new health care program, they compare the program's expected cost against its ... Background: Cost-effectiveness analysis is an important tool for informing treatment coverage and pricing decisions, yet no consensus exists about what threshold for the incremental cost-effectiven...Keywords
This publication has 55 references indexed in Scilit:
- The Oregon Health Insurance Experiment: Evidence from the First Year*The Quarterly Journal of Economics, 2012
- Health outcomes in economic evaluation: the QALY and utilitiesBritish Medical Bulletin, 2010
- What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?Medical Care, 2008
- Welfarism vs. extra-welfarismJournal of Health Economics, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Medicare And Cost-Effectiveness Analysis: Time To Ask The TaxpayersHealth Affairs, 2007
- Incremental cost-effectiveness ratios (ICERs): The silence of the lambdaSocial Science & Medicine, 2006
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- HALYs and QALYs and DALYs, Oh My: Similarities and Differences in Summary Measures of Population HealthAnnual Review of Public Health, 2002
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997